Paul A. Brennan
Corporate Officer/Principal at EUPRAXIA PHARMACEUTICALS INC.
Net worth: 77 520 $ as of 2024-04-29
Network origin in Paul A. Brennan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 | |
| Public Company | Biotechnology | 13 | |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases.
12
| Extinct | Pharmaceuticals: Major | 12 |
| Public Company | Pharmaceuticals: Major | 12 | |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.
8
| Extinct | Pharmaceuticals: Major | 8 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
6
| Extinct | Pharmaceuticals: Major | 6 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada.
5
| Extinct | Pharmaceuticals: Major | 5 |
| Public Company | Financial Conglomerates | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paul A. Brennan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Founder Founder Chief Executive Officer Human Resources Officer Public Communications Contact | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Chief Executive Officer | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Chairman Chairman Director/Board Member Chairman | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Public Communications Contact Human Resources Officer | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| Accuro Technologies, Inc. | Director/Board Member Chairman Chief Executive Officer | ||
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Indiana University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| The University of Waterloo | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Founder Director of Finance/CFO | |
| BC Technology Industry Association | Director/Board Member Director/Board Member Director/Board Member | ||
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Victoria | College/University | Masters Business Admin Masters Business Admin | |
Anandia Laboratories, Inc.
 Anandia Laboratories, Inc. BiotechnologyHealth Technology Anandia Laboratories, Inc. operates as a cannabis biotechnology firm. It also offers analytical testing services including potency, pesticides, microbes, and terpenes to licensed producers and patients. The company was founded by Jonathan Page and John Coleman on November 26, 2013 and is headquartered in Vancouver, Canada. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Director of Finance/CFO Director of Finance/CFO | |
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chairman Founder | |
| XORTX THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| McMaster University | College/University | Undergraduate Degree Undergraduate Degree | |
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Biotechnology | Chairman Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chief Executive Officer Director/Board Member | |
Vancouver Aquarium
 Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Part of Herschend Family Entertainment Corp., Vancouver Aquarium operates an aquarium. The company is based in Vancouver, Canada. Vancouver Aquarium was acquired by Herschend Family Entertainment Corp. from Ocean Wise Conservation Association on April 15, 2021. The Canadian company was founded in 1951. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Junior Achievement British Columbia | Director/Board Member Director/Board Member | ||
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Public Communications Contact | |
| TIMIA CAP CO | Miscellaneous | Director/Board Member Chief Executive Officer | |
| Queen's University | College/University | Undergraduate Degree Masters Business Admin | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| St. Paul’s Hospital Foundation | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| PERIMETER MEDICAL IMAGING AI, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Chairman | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistics
International
| Canada | 33 |
| United States | 16 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Miscellaneous | 4 |
| Finance | 3 |
Operational
| Director/Board Member | 330 |
| Corporate Officer/Principal | 141 |
| Independent Dir/Board Member | 79 |
| Chairman | 77 |
| Director of Finance/CFO | 64 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Geyer | 37 |
| Ken Galbraith | 30 |
| Bruce A. Schmidt | 29 |
| Michael Hayden | 27 |
| Richard Glickman | 26 |
| Gary E. Frashier | 26 |
| R. MacKay-Dunn | 26 |
| George Milne | 24 |
| Simon Pimstone | 22 |
| John Montalbano | 22 |
| Ronald Ian Lennox | 22 |
| Glenn Ives | 19 |
| Michael Jeffrey Abrams | 16 |
| J. William Freytag | 16 |
| Adam Daniel Cutler | 16 |
- Stock Market
- Insiders
- Paul A. Brennan
- Company connections